WEST PHARMACEUTICAL SERVICES INC
WSTAPI behind this page
WST Q2 2025 request
Playground key active
/api/financials?ticker=WST&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Revenue | 766.5 | 702.1 | +9.2% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products | 146.7 | 142.4 | +3.0% |
| Contract-Manufactured Products · Operating Segments | 146.7 | 142.4 | +3.0% |
| Proprietary Products | 619.8 | 559.7 | +10.7% |
| Proprietary Products · Operating Segments | 619.8 | 559.7 | +10.7% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Foreign Exchange Contract | -0.3 | 0.1 | -400.0% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 766.5 | 702.1 | +9.2% |
Show Related Party Transactions By Related Party breakouts |
|||
| Affiliated Entity | 2.8 | 4 | -30.0% |
| Cost of Revenue | 492.6 | 472.1 | +4.3% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 121.1 | 119.4 | +1.4% |
| Proprietary Products · Operating Segments | 371.5 | 352.7 | +5.3% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Foreign Exchange Contract | -0.5 | 1.8 | -127.8% |
| Gross Profit | 273.9 | 230 | +19.1% |
| Research & Development | 19.1 | 17.5 | +9.1% |
Show Business Segments breakouts |
|||
| Proprietary Products · Operating Segments | 19.1 | 17.5 | +9.1% |
| Selling, General & Administrative | 95.9 | 83 | +15.5% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 7 | 6.2 | +12.9% |
| Proprietary Products · Operating Segments | 61.5 | 56.1 | +9.6% |
| Other Income Expense | 5.2 | 3.3 | +57.6% |
| Operating Income | 153.7 | 126.2 | +21.8% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 17.8 | 17.2 | +3.5% |
| Proprietary Products · Operating Segments | 161.7 | 131 | +23.4% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 179.5 | 148.2 | +21.1% |
| Interest Expense | 0.1 | 1.5 | -93.3% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Treasury Lock | 0.1 | — | — |
| Investment Income Net | -3.6 | -4 | +10.0% |
| Other Non-Operating Income (Expense) | 0.2 | — | — |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 157 | 128.7 | +22.0% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income | 0.2 | 0.2 | 0.0% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 0.1 | -0.7 | +114.3% |
| Income Tax Expense (Benefit) | 30.2 | 21.9 | +37.9% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income | 0.1 | — | — |
| Income Loss From Equity Method Investments | -5 | -4.5 | -11.1% |
| Net Income | 131.8 | 111.3 | +18.4% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income | 0.1 | 0.2 | -50.0% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 0.1 | -0.6 | +116.7% |
| Retained Earnings | 131.8 | 111.3 | +18.4% |
Show Reclassification Out Of Accumulated Other Comprehensive Income breakouts |
|||
| Reclassification Out Of Accumulated Other Comprehensive Income | 0.2 | -0.4 | +150.0% |
| EPS (Basic) | 1.82 | 1.52 | +19.7% |
| EPS (Diluted) | 1.82 | 1.51 | +20.5% |
| Wtd Avg Shares (Basic) | 72.2 | 73 | -1.1% |
| Wtd Avg Shares (Diluted) | 72.5 | 73.7 | -1.6% |
| General & Administrative (Q) | — | — | — |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | -16.8 | -17.5 | +4.0% |
| Income Before Taxes | 157 | 128.7 | +22.0% |
| Comprehensive Income | 248.6 | 86.7 | +186.7% |
| Other Comprehensive Income | 116.8 | -24.6 | +574.8% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 116.8 | -24.6 | +574.8% |
| Foreign Currency Transaction Gain Loss Before Tax | 1.7 | 2 | -15.0% |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 509.7 | 446.2 | +14.2% |
| Accounts Receivable | 582.4 | 479.4 | +21.5% |
| Inventory | 421.1 | 419.2 | +0.5% |
| Other Assets Current | 167.7 | 138.2 | +21.3% |
Show Related Party Transactions By Related Party breakouts |
|||
| Affiliated Entity | 2.2 | 2.4 | -8.3% |
| Total Current Assets | 1,680.9 | 1,483 | +13.3% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 1,722 | 1,493.7 | +15.3% |
| Operating Lease Right-of-Use Assets | 104.4 | 110.3 | -5.3% |
| Goodwill | 110.9 | 107.3 | +3.4% |
| Deferred Tax Assets | 29.7 | 33.9 | -12.4% |
| Other Non-Current Assets | 70.5 | 50.1 | +40.7% |
| Total Assets | 3,952.8 | — | — |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 667.9 | — | — |
| Proprietary Products · Operating Segments | 2,829.3 | — | — |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | 455.6 | — | — |
| Other Assets | |||
| Property Plant And Equipment Gross | 3,177.6 | 2,863.6 | +11.0% |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 1,455.6 | 1,369.9 | +6.3% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 224.7 | — | — |
| Intangible Assets Net Excluding Goodwill | 9.7 | 12.9 | -24.8% |
| Current Liabilities | |||
| Accounts Payable | 239 | 211.7 | +12.9% |
| Accrued Salaries Wages And Benefits Current | 93.4 | 82.9 | +12.7% |
| Accrued Income Taxes Current | 28.5 | 16.9 | +68.6% |
| Operating Lease Liability Current | 20.9 | 20.3 | +3.0% |
| Other Liabilities Current | 222.8 | 169 | +31.8% |
Show Related Party Transactions By Related Party breakouts |
|||
| Affiliated Entity | 24.8 | 20.4 | +21.6% |
| Total Current Liabilities | 604.6 | 633.7 | -4.6% |
| Non-Current Liabilities | |||
| Long-Term Debt | 202.6 | 72.9 | +177.9% |
| Deferred Tax Liabilities | 23 | 13.7 | +67.9% |
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 30.8 | 29.1 | +5.8% |
| Operating Lease Liabilities | 79.8 | 84.6 | -5.7% |
| Deferred Compensation Liability Classified Noncurrent | 12.5 | 15.5 | -19.4% |
| Other Non-Current Liabilities | 70.4 | 63.1 | +11.6% |
| Total Liabilities | 1,023.7 | 912.6 | +12.2% |
| Long-Term Debt | 202.6 | 205.8 | -1.6% |
| Stockholders' Equity | |||
| Common Stock | 18.8 | 18.8 | 0.0% |
| Retained Earnings | 4,139.2 | 3,720.9 | +11.2% |
| Accumulated Other Comprehensive Income | -88.7 | -216.9 | +59.1% |
| Treasury Stock Common Value | -1,140.2 | -979.5 | -16.4% |
| Total Stockholders' Equity | 2,929.1 | 2,576.8 | +13.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -10.9 | -10.5 | -3.8% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 2.5 | -4.5 | +155.6% |
| Accumulated Other Comprehensive Income | -88.7 | -216.9 | +59.1% |
| Accumulated Translation Adjustment | -83 | -204 | +59.3% |
| Aoci Equity Method Investment Parent | 2.7 | 2.1 | +28.6% |
| Common Stock | 18.8 | 18.8 | 0.0% |
| Retained Earnings | 4,139.2 | 3,720.9 | +11.2% |
| Treasury Stock Common | -1,140.2 | -979.5 | -16.4% |
| Total Liabilities & Equity | 3,952.8 | 3,489.4 | +13.3% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation | 79.9 | 72.7 | +9.9% |
| Adjustment For Amortization | 1.5 | 1.8 | -16.7% |
| Stock-Based Compensation | 8.7 | 9.3 | -6.5% |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | 8.7 | 9.3 | -6.5% |
| Restructuring Charges | 1.6 | — | — |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | 19.4 | — | — |
| Corporate And Reconciling Items · Other Income (Expense) | 16.6 | — | — |
| Corporate And Reconciling Items · Selling General And Administrative Expenses | 2.8 | — | — |
| Asset Impairment Charges | 4.1 | 0.9 | +355.6% |
| Other Non-Cash Items | -6.9 | -7.6 | +9.2% |
| Increase Decrease In Operating Capital | -4 | -20.5 | +80.5% |
| Net Cash from Operations | 306.5 | 283.2 | +8.2% |
| Depreciation & Amortization | 81.4 | 74.5 | +9.3% |
Show Business Segments breakouts |
|||
| Contract-Manufactured Products · Operating Segments | 13.2 | 9.6 | +37.5% |
| Proprietary Products · Operating Segments | 66.4 | 63 | +5.4% |
Show Consolidation Items breakouts |
|||
| Corporate And Reconciling Items | 1.8 | 1.9 | -5.3% |
| Change in Deferred Revenue | 7 | 1.7 | +311.8% |
| Investing Activities | |||
| Capital Expenditures | -146.5 | -190.8 | +23.2% |
| Net Cash from Investing | -146.5 | -191.8 | +23.6% |
| Financing Activities | |||
| Finance Lease Principal Payments | -0.5 | -22.9 | +97.8% |
| Payments For Excise Tax | -4.2 | — | — |
| Payments Of Dividends Common Stock | -30.3 | -29.3 | -3.4% |
| Proceeds From Stock Options Exercised | 6 | 19.9 | -69.8% |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 3.6 | 3.7 | -2.7% |
| Share Repurchases | -134 | -454.1 | +70.5% |
| Tax Withholding for Share Compensation | -2.5 | -5.5 | +54.5% |
| Net Cash from Financing | -161.9 | -489.3 | +66.9% |
| Supplemental | |||
| Unpaid Capital Expenditures | 35.4 | 41.6 | -14.9% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 27 | -9.8 | +375.5% |
| Net Change in Cash | 25.1 | -407.7 | +106.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 509.7 | 446.2 | +14.2% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.